LWAM
GMAB icon

Legacy Wealth Asset Management’s Genmab GMAB Stock Holding History

Legacy Wealth Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.81M Buy
102,164
+63,484
+164% +$1.69M 0.62% 25
2026
Q1 		$1.04M Buy
38,680
+16,652
+76% +$499K 0.25% 115
2025
Q4 		$678K Sell
22,028
-24,559
-53% -$765K 0.17% 198
2025
Q3 		$1.43M Sell
46,587
-431
-0.9% -$10.5K 0.35% 75
2025
Q2 		$971K Sell
47,018
-2,349
-5% -$48.2K 0.25% 105
2025
Q1 		$967K Buy
49,367
+13,246
+37% +$278K 0.27% 92
2024
Q4 		$754K Sell
36,121
-8,858
-20% -$195K 0.21% 136
2024
Q3 		$1.1M Buy
44,979
+471
+1% +$12.6K 0.29% 94
2024
Q2 		$1.12M Buy
44,508
+7,805
+21% +$221K 0.32% 84
2024
Q1 		$1.1M Buy
36,703
+1,611
+5% +$47.3K 0.31% 87
2023
Q4 		$1.12M Buy
35,092
+5,596
+19% +$176K 0.37% 80
2023
Q3 		$1.04M Buy
29,496
+13,544
+85% +$516K 0.38% 82
2023
Q2 		$606K Buy
15,952
+116
+0.7% +$4.63K 0.21% 160
2023
Q1 		$598K Buy
15,836
+5,233
+49% +$201K 0.22% 156
2022
Q4 		$449K Sell
10,603
-5,410
-34% -$223K 0.17% 211
2022
Q3 		$514K Buy
+16,013
New +$562K 0.22% 157

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Legacy Wealth Asset Management's GMAB Position: Q2 2026 in Review

Legacy Wealth Asset Management increased its Genmab (GMAB) stake by 164% in Q2 2026, buying an estimated $1.69M and bringing the position to 102,164 shares worth $2.81M. The position accounts for 0.62% of the portfolio, ranked #25.

Legacy Wealth Asset Management first reported a position in GMAB in Q3 2022 and has held it in 16 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Legacy Wealth Asset Management held 102,164 shares of Genmab worth $2.81M as of Q2 2026.
  • Legacy Wealth Asset Management bought 63,484 Genmab shares in Q2 2026, an estimated $1.69M.
  • Genmab made up 0.62% of Legacy Wealth Asset Management's portfolio in Q2 2026, its #25 holding.
  • Legacy Wealth Asset Management first reported a position in Genmab in Q3 2022 and has held it in 16 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Legacy Wealth Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.